Patient grouping by recovery group and drug mechanism.

NIAID Data Ecosystem2026-03-13 收录

患者分层

药物机制分析

数据链接：

https://figshare.com/articles/dataset/Patient_grouping_by_recovery_group_and_drug_mechanism_/20148549 数据链接链接失效反馈

官方服务：

资源简介：

Patient grouping by recovery group and drug mechanism.

创建时间：

2022-06-24

Additional file 1: of Immune-enrichment of non-small cell lung cancer baseline biopsies for multiplex profiling define prognostic immune checkpoint combinations for patient stratification

癌症免疫治疗

患者分层

Figure S1. Methods, antibodies and validation that IIC-density does not correlate with patient clinicopathological characteristics. Figure S2. CD45 distribution on TMA cores and K-M plots of immune ce

DataCite Commons2020-08-27 更新80

Supplementary Material for: Key prognostic factors create a composite risk score to stratify patients into high- and low treatment benefit groups: A multicenter, retrospective data analysis of 84 mCRC patients treated with regorafenib as part of the CORRECT and CONSIGN trials

肿瘤学

患者分层

Introduction: In further-line mCRC treatment, median progression-free survival (PFS) is rather short, and many patients do not benefit from any anti-tumor treatment and should therefore treated accord

DataCite Commons2023-05-30 更新50

Characteristics of study patients stratified by warfarin users versus non-users in derivation and validation cohort.

华法林

患者分层

Characteristics of study patients stratified by warfarin users versus non-users in derivation and validation cohort.

NIAID Data Ecosystem30

CD4_counts_table_S2.tab

免疫监测

患者分层

CSV file containing the CD4+ T cell count values (trajectories) of each patient and the corresponding patient cluster.

DataCite Commons2021-07-23 更新70

Classification of study population according to clinical and microbiological data.